Recent News

TAT 2020: IL-18 and Anticancer Immunity in Prostate Cancer

Head/Neck Cancers Symposium 2020: Immunotherapy Plus TKIs in Metastatic Thyroid Cancer

New Receptor Protein May Successfully Target Multiple Myeloma Cells

RTK Inhibitor Plus Immunotherapy in Advanced Kidney Cancer

Can Influenza Vaccines Trigger Immune Response in Patients With Lung Cancer?

Combination Therapy for Enzalutamide-Resistant Prostate Cancer

FDA Accepts Biologics License Application for Proposed Biosimilar to Bevacizumab

FDA Accepts Biologics License Application for Proposed Biosimilar To Bevacizumab

Bempegaldesleukin and Adoptive Cell Transfer Therapy: Preclinical Melanoma Model

FDA Accepts Biologics License Application for Proposed Biosimilar to Bevacizumab

Head/Neck Cancers Symposium 2020: SBRT Plus Pembrolizumab in Previously Irradiated Squamous Cell Carcinoma

FDA Accepts BLA for Fixed-Dose Combination Therapy for HER2-Positive Breast Cancer

Isatuximab-irfc Combination Therapy for Multiple Myeloma Approved by FDA

GU Cancers Symposium 2020: Update From CheckMate 214 on First-Line Nivolumab Plus Ipilimumab for Kidney Cancer

Can TKIs Combined With Interferon-α Enhance Immunosuppressive State in CML?

TAPUR Results for Cobimetinib Plus Vemurafenib in Colorectal Cancer

Addition of Gemtuzumab Ozogamicin to Induction Therapy in AML

Atezolizumab Receives FDA Priority Review in NSCLC

GI Cancers Symposium 2020: AVETUX Regimen in Metastatic Colorectal Cancer

GU Cancers Symposium 2020: Savolitinib Plus Durvalumab in Papillary Renal Carcinoma

GU Cancers Symposium 2020: Dual Immune Checkpoint Inhibition With Radiation for Kidney Cancer

ASCO-SITC 2020: Sociodemographics and Receipt of Immunotherapy in Advanced Melanoma

Daratumumab-Based Combination Therapy for Newly Diagnosed Multiple Myeloma

ASCO-SITC 2020: Genetics Research Hints at Regulator of T-Cell Responses in Colorectal Cancer

GU Cancers Symposium 2020: Long-Term Data Support Nivolumab vs Everolimus in Kidney Cancer

ASCO–SITC 2020: Interim Trial Results With Pepinemab/Avelumab in Advanced NSCLC

Can Influenza Vaccines Trigger Immune Response in Patients With Melanoma?

GI Cancers Symposium 2020: Pertuzumab Plus Trastuzumab in HER2-Positive Colorectal Cancer

ASCO-SITC 2020: Radiation Recall Pneumonitis and Nivolumab for Lung Cancer

Phase I Trial Results With Immunotherapy bb21217 for Resistant Multiple Myeloma

ASCO-SITC 2020: Is Immune Primer in Renal Cell Cancer Ready for Prime Time?

Dynamics of DNA Methylation in CLL Patients Treated With Chemoimmunotherapy

NCI-MATCH Study: Next Phase for Nivolumab Beyond Colorectal Cancer

Matching Tumor Mutations to Treatment for Salivary Gland Cancer

GI Cancers Symposium 2020: TAPUR Study Findings for Pembrolizumab in Colorectal Cancer

B and T Immune Cells: A Biomarker of Response to Immunotherapy for Breast Cancer?

GI Cancers Symposium 2020: Quality-of-Life Results From the BEACON CRC Trial